Skip to content
The Nexus
DossierENTITY

IDEA Pharma

Coverage of IDEA Pharma in the Nexus archive.

Earliest in view: May 19 · 12:00 UTCMost recent: May 19 · 13:55 UTC
Co-mentioned in this coverage
Eli Lillyorganization2Relay Therapeuticsorganization1zovegalisibtopic1San Franciscoplace1SAI MedPartnersorganization1
Recent coverage
  • HEALTHMay 19 · 13:55 UTCSTAT NEWS
    STAT+: A new ranking of pharma companies by R&D performance

    Eli Lilly ranked first in two categories for R&D performance, while Relay Therapeutics reported promising Phase 2 data for its drug zovegalisib. This led to a 9% increase in company shares during premarket trading. IDEA Pharma conducts the annual ranking of pharma companies.

  • HEALTHMay 19 · 12:00 UTCSTAT NEWS
    STAT+: Eli Lilly tops prominent rankings on pharma R&D performance

    Eli Lilly ranked first in both innovation and invention categories in a pharmaceutical R&D performance index produced by IDEA Pharma. The index ranks drug companies based on criteria such as revenue from new products and R&D investment. This is the first time one company has topped both categories.